Andrew B Nixon (Andrew Nixon)

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 22

Top Topics

Metastatic Colorectal Cancer

Gene Expression

Top Venues

Cancer research communications

Clinical cancer research : an official journal of the American Association for Cancer Research

Research square

JNCI cancer spectrum

This page only lists publications with an associated author ORCID identifier.

Publications

Akram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, Gianluigi Pillonetto, Esmat Samiei, Reza Hadi, Heinz-Josef Lenz, Alan Venook, Ahmad Samiei, Andrew B Nixon, Joseph Lucci, Edmund S Kopetz, Monica Bertagnolli, Charles Perou, Federico Innocenti
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies. Research square (2024)
Andrew Hall, Sarah R Brown, Niharika B Mettu, Paul C Miller, Elizabeth C Smyth, Andrew B Nixon
Incorporating Molecular Data Into Treatment Decision Making in Gastroesophageal and Pancreaticobiliary Cancers: Timing and Strategies. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 44 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Akram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, Gianluigi Pillonetto, Esmat Samiei, Reza Hadi, Heinz-Josef Lenz, Alan Venook, Ahmad Samiei, Andrew B Nixon, null null, Edmund S Kopetz, Monica Bertagnolli, Charles Perou, Federico Innocenti
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies. Research square (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma. Cancer research communications (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma. Cancer research communications (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Akram Yazdani, Azam Yazdani, Raul Mendez-Giraldez, Gianluigi Pillonetto, Esmat Samiei, Reza Hadi, Heinz-Josef Lenz, Alan Venook, Ahmad Samiei, Andrew B Nixon, null null, Edmund S Kopetz, Monica Bertagnolli, Charles Perou, Federico Innocenti
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies. Research square (2024)
Ghassan K Abou-Alfa, Susan M Geyer, Andrew B Nixon, Federico Innocenti, Qian Shi, Priya U Kumthekar, Sawyer Jacobson, Imane El Dika, Amin Yaqubie, Juan Lopez, Binhui Huang, Yi-Wei Tang, Yujia Wen, Lawrence H Schwartz, Anthony B El-Khoueiry, Jennifer J Knox, Lakshmi Rajdev, Monica M Bertagnolli, Jeffrey A Meyerhardt, Eileen M O'Reilly, Alan P Venook
CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer research communications 4 (3) (2024)
Alex Seok Choi, Laura M Jenkins, Wade Barton, Asha Kumari, Carly L Lancaster, Calen Raulerson, Hao Ji, Diego Altomare, Mark D Starr, Regina Whitaker, Rebecca Phaeton, Rebecca C Arend, Michael S Shtutman, Andrew B Nixon, Nadine Hempel, Nam Y Lee, Karthikeyan Mythreye
Heparan sulfate modifications of betaglycan promote TIMP3-dependent ectodomain shedding to fine-tune TGF-β signaling. bioRxiv : the preprint server for biology (2023)
Andrew B Nixon, Susan Halabi, Yingmiao Liu, Mark D Starr, John C Brady, Ivo Shterev, Bin Luo, Herbert I Hurwitz, Phillip G Febbo, Brian I Rini, Himisha Beltran, Eric J Small, Michael J Morris, Daniel J George
Predictive Biomarkers of Overall Survival in Patients with Metastatic Renal Cell Carcinoma Treated with IFNα ± Bevacizumab: Results from CALGB 90206 (Alliance). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Jingquan Jia, Lauren Howard, Yingmiao Liu, Mark D Starr, John C Brady, Donna Niedzwiecki, John H Strickler, Andrew B Nixon
Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers. Cancer chemotherapy and pharmacology 89 (3) (2022)
Andrew B Nixon, Alexander B Sibley, Yingmiao Liu, Ace J Hatch, Chen Jiang, Flora Mulkey, Mark D Starr, John C Brady, Donna Niedzwiecki, Alan P Venook, Luis Baez-Diaz, Heinz-Josef Lenz, Bert H O'Neil, Federico Innocenti, Jeffrey A Meyerhardt, Eileen M O'Reilly, Kouros Owzar, Herbert I Hurwitz
Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance). Clinical cancer research : an official journal of the American Association for Cancer Research 28 (13) (2022)
Andrew J Armstrong, Andrew B Nixon, Andrea Carmack, Qian Yang, Tim Eisen, Walter M Stadler, Robert J Jones, Jorge A Garcia, Ulka N Vaishampayan, Joel Picus, Robert E Hawkins, John D Hainsworth, Christian K Kollmannsberger, Theodore F Logan, Igor Puzanov, Lisa M Pickering, Christopher W Ryan, Andrew Protheroe, Daniel J George, Susan Halabi
Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (12) (2021)
Erika J Lampert, Alexandra S Zimmer, Michelle Padget, Ashley Cimino-Mathews, Jayakumar R Nair, Yingmiao Liu, Elizabeth M Swisher, James W Hodge, Andrew B Nixon, Erin Nichols, Mohammad Hadi Bagheri, Elliott Levy, Marc R Radke, Stanley Lipkowitz, Christina M Annunziata, Janis M Taube, Seth M Steinberg, Jung-Min Lee
Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (16) (2020)
Mark J A Schoonderwoerd, Maaike F M Koops, Ricardo A Angela, Bryan Koolmoes, Melpomeni Toitou, Madelon Paauwe, Marieke C Barnhoorn, Yingmiao Liu, Cornelis F M Sier, James C H Hardwick, Andrew B Nixon, Charles P Theuer, Marieke F Fransen, Lukas J A C Hawinkels
Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Yingmiao Liu, Jing Lyu, Kirsten Bell Burdett, Alexander B Sibley, Ace J Hatch, Mark D Starr, John C Brady, Kelli Hammond, Federica Marmorino, Daniele Rossini, Richard M Goldberg, Alfredo Falcone, Chiara Cremolini, Kouros Owzar, Anastasia Ivanova, Dominic T Moore, Michael S Lee, Hanna K Sanoff, Federico Innocenti, Andrew B Nixon
Prognostic and Predictive Biomarkers in Patients with Metastatic Colorectal Cancer Receiving Regorafenib. Molecular cancer therapeutics 19 (10) (2020)
Brendan J Guercio, Sui Zhang, Fang-Shu Ou, Alan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, Federico Innocenti, Michael N Pollak, Andrew B Nixon, Brian C Mullen, Bert H O'Neil, James E Shaw, Blase N Polite, Al Bowen Benson, James N Atkins, Richard M Goldberg, Justin C Brown, Eileen M O'Reilly, Robert J Mayer, Charles David Blanke, Charles S Fuchs, Jeffrey A Meyerhardt
IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405. JNCI cancer spectrum 5 (1) (2020)
Yingmiao Liu, Madelon Paauwe, Andrew B Nixon, Lukas J A C Hawinkels
Endoglin Targeting: Lessons Learned and Questions That Remain. International journal of molecular sciences 22 (1) (2020)
Ace J Hatch, Alexander B Sibley, Mark D Starr, J Chris Brady, Chen Jiang, Jingquan Jia, Daniel L Bowers, Herbert Pang, Kouros Owzar, Donna Niedzwiecki, Federico Innocenti, Alan P Venook, Herbert I Hurwitz, Andrew B Nixon, null null
Blood-based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance). Cancer medicine 5 (9) (2016)